ArticlePharmaceutics2023

Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction.

Naomi Chadderton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.